Collaborate Disseminate
Moderna has announced the results of a Phase 2b trial investigating its mRNA treatment for skin cancer, and it continues a streak of promising news. When paired with an immunotherapy, the treatment significantly reduced the risks of recurrence, metasta… Continue reading mRNA skin cancer therapy halves risk of death in clinical trial
Moderna, one pharmaceutical company inextricably linked to the pandemic vaccination response, has announced it will take its new seasonal influenza and COVID-19 combination shot to Phase 3 trials after “strong” results in Phase 1/2 stages of testing. I… Continue reading “Strong” Phase 1/2 trial results for Moderna’s flu-COVID-19 combo jab
In-depth report looks at how COVID-19 research has become as a juicy new target for organized cybercrime. Continue reading Hackers Amp Up COVID-19 IP Theft Attacks
Cybercriminals try to steal the credentials of top companies associated with the COVID-19 vaccine supply chain in an espionage effort. Continue reading Cyberattacks Target COVID-19 Vaccine ‘Cold-Chain’ Orgs